CORDENPHARMA CAPONAGO (IT)

Core Capabilities

  • >> Experts in formulating and packaging parenteral dosage forms
  • >> Sterile emulsion technology
  • >> Pre-filled syringes
  • >> Distribution of clinical trial medication
  • >> Formulation development

COMPLIANCE

  • >> EMEA (AIFA)
  • >> FDA
  • >> ANVISA
  • >> TGA
  • >> Japanese MoH

Facility Legacy

CordenPharma Caponago is a cGMP manufacturer of a wide range of sterile liquid dosage forms for injectable use with specialised expertise in terminal sterilization, aseptic fill & finish operations and sterile emulsion technology. The site has full range of capabilities including formulation development, manufacturing, clinical trials management and packaging & pharma-logistics.

As a former AstraZeneca operations site, CordenPharma Caponago brings over 20 years of experience to CordenPharma’s full-service CDMO platform. The site is inspected by EMA (AIFA), FDA, ANVISA, TGA, and the Japanese Authority.

HISTORY

  • >> 1970 Foundation
  • >> 1987 Expansion to accommodate Diprivan
  • >> 1991 Further expansion
  • >> 1992 First FDA approval
  • >> 2001 Acquired ex–Upjohn Plant
  • >> 2005 New plant for Carbapenemic packaging and analysis
  • >> 2007 Latest Anvisa (Brasilian) Audit
  • >> 2009 Acquired by ICIG to become Corden Pharma Caponago S.p.A.
  • >> 2009 Latest FDA Audit
  • >> 2009 Latest Italian MoH Audit (AIFA)
  • >> 2011 Italian AIFA & FDA combined audit
  • >> 2012 Italian MoH Veterinary approval
  • >> 2016 Italian MoH (EU) approval of New Aseptic Dept
 

Managing Director

Fabrizio Fiordigiglio

Corden Pharma Caponago S.p.A.

Viale dell’Industria, 3
20867 Caponago
Monza Brianza
Italy

Phone: +39 02 95452 1
Fax: +39 02 95452 300

Email Human Resources